GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB
- Liu, Z., Wang, Y., Yang, F., Yang, Q., Mo, X., Burstein, E., Jia, D., Cai, X.T., Tu, Y.
- Molecular biomedicine 2: 13 (Journal)
- Registered Authors
- Mo, Xianming
- Congenital disorders of glycosylation, Enzymatic activity, GMPPB, Zebrafish model
- MeSH Terms
- 35006422 Full text @ Mol Biomed
Liu, Z., Wang, Y., Yang, F., Yang, Q., Mo, X., Burstein, E., Jia, D., Cai, X.T., Tu, Y. (2021) GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB. Molecular biomedicine. 2:13.
The congenital disorders of glycosylation (CDG) are a family of metabolic diseases in which glycosylation of proteins or lipids is deficient. GDP-mannose pyrophosphorylase B (GMPPB) mutations lead to CDG, characterized by neurological and muscular defects. However, the genotype-phenotype correlation remains elusive, limiting our understanding of the underlying mechanism and development of therapeutic strategy. Here, we report a case of an individual presenting congenital muscular dystrophy with cerebellar involvement, who presents two heterozygous GMPPB mutations (V111G and G214S). The V111G mutation significantly decreases GMPPB's enzymatic activity. By measuring enzymatic activities of 17 reported GMPPB mutants identified in patients diagnosed with GMPPB-CDG, we discover that all tested GMPPB variants exhibit significantly decreased enzymatic activity. Using a zebrafish model, we find that Gmppb is required for neuronal and muscle development, and further demonstrate that enzymatic activity of GMPPB mutants correlates with muscular and neuronal phenotypes in zebrafish. Taken together, our findings discover the importance of GMPPB enzymatic activity for the pathogenesis of GMPPB-CDG, and shed light for the development of additional indicators and therapeutic strategy.
Genes / Markers
Mutation and Transgenics
Human Disease / Model Data
Sequence Targeting Reagents
Engineered Foreign Genes
Errata and Notes